
News|Articles|January 1, 2002
Real-world study finds "unequivocal"lack of difference among SSRIs
The selective serotonin reuptake inhibitors (SSRIs) fluoxetine, sertraline,and paroxetine are equally effective and tolerated in depressed patientsacross a broad range of outcome measures. So finds an open-label, randomizedstudy in 573 patients treated for depression for 9 months in a primary caresetting.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payers Are Bracing for the Specialty Trend of the Future | AMCP Nexus 2025
2
HPV Vaccine Still Highly Effective 17 Years After Introduction
3
Stressful Family Changes in Early Childhood Could Increase Psoriasis Risk
4
Real-World Study Shows $330,000 Cost Difference Between CAR T and BiTE Therapies | AMCP Nexus 2025
5



















































